New Zealand markets open in 8 hours 20 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
160.07-7.45 (-4.45%)
At close: 04:00PM EST
157.30 -2.77 (-1.73%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close167.52
Bid157.30 x 1000
Ask158.00 x 900
Day's range157.29 - 171.25
52-week range117.34 - 497.49
Avg. volume11,892,540
Market cap64.9B
Beta (5Y monthly)1.21
PE ratio (TTM)9.59
EPS (TTM)16.69
Earnings date23 Feb 2022 - 28 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est284.26
  • Motley Fool

    Moderna Is Betting on a New Way to Fight Cancer

    The COVID-19 vaccine maker is jumping into CAR-M technology with its deal with Carisma Therapeutics.

  • Motley Fool

    1 Green Flag for Novavax in 2022, and 1 Red Flag

    Novavax (NASDAQ: NVAX) is arriving more than a year after market leaders Pfizer and Moderna to the coronavirus vaccine finish line. Novavax soared 2,700% in 2020. As of today, Novavax's vaccine has won authorization from more than 30 countries.

  • Motley Fool

    The Worst Mistake Moderna Investors Can Make in 2022

    Moderna (NASDAQ: MRNA) has come a long way in just two years. The biotech company developed one of the leading coronavirus vaccines in about nine months -- and has since made billions of dollars in vaccine revenue and profit.